Women's Health
GLP-1 Weight-Loss Medication for Women Over 40: What the Evidence Shows
What GLP-1 trials do and don't establish for women over 40: midlife body composition, lean mass, bone health, maintenance after stopping, and open questions.
Semaglutide for Women: What the Clinical Trials Actually Show (2026)
The real numbers behind semaglutide weight loss for women — average results, timelines and side effects from the pivotal STEP 1 trial, without the marketing gloss.
GLP-1 Weight-Loss Medication for Women: Every Question, Answered With Sources (2026)
Results, costs, side effects, safety, the compounding crackdown and how to choose a telehealth program — the complete evidence-cited GLP-1 FAQ for women.
Wegovy vs Zepbound for Women: The Trial-by-Trial Comparison (2026)
Semaglutide (Wegovy) vs tirzepatide (Zepbound) for women: what the STEP 1, SURMOUNT-1, and head-to-head SURMOUNT-5 trials actually found on weight loss, side effects, and cost trade-offs.
GLP-1 Side Effects in Women: What the Trials Report (2026)
What the STEP 1 and SURMOUNT-1 trials report about GLP-1 side effects — the GI-dominant profile, the 4.5% discontinuation figure, the serious risks prescribers screen for, and when to call a clinician.
GLP-1s, Pregnancy and Fertility: What Women Planning a Family Need to Know (2026)
GLP-1 weight-loss medications are not for use in pregnancy. What that means if you are planning a family: stopping in advance, fertility effects to discuss with a clinician, contraception conversations, and what to do if you become pregnant on the medication.